
Anti-Taq Monoclonal Antibody/T
aq酶单克隆抗体相关产品推荐更多 >

Anti-Human CD81 Antibody (005-C01)
¥2300
WNT4抗体WNT4兔多抗抗体WNT4_HUMAN antibody抗体WNT4 Antibody抗体
¥440
Dengue virus NS3 protein antibody
¥1700
GAPDH Recombinant Rabbit mAb, Loading Control(bsm-52262R)-50ul/100ul/500ul
¥680
NFKBIA抗体NFKBIA一抗抗体Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha antibody抗体Phospho-NFKBIA (S32/S36) Antibody抗体
¥880
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 形态:
液体
- 保存条件:
-20
- 克隆性:
多克隆
- 应用范围:
QPCR,分子诊断,杂交
- 浓度:
5000U/ml
- 靶点:
Taq
- 抗体英文名:
Anti-Taq Monoclonal Antibody
- 抗体名:
Taq酶单克隆抗体
Anti-Taq Monoclonal Antibody 是热启动PCR专用的抗Taq单克隆抗体,常温下与Taq酶结合后, Taq酶的活性被封闭。用本产品进行PCR扩增反应时,最初抗Taq单克隆抗体与Taq酶结合,Taq DNA 聚合酶的活性被抑制,常温条件下可以有效降低由引物的非特异性退火及引物二聚体引起的非特异性扩增。在PCR反应初始的预变性步骤结束后,抗Taq单克隆抗体高温受热失活,释放出Taq酶的活性,从而达到了热启动PCR的效果。本产品无需特殊的抗Taq抗体失活处理。可以在常规PCR反应条件下使用。
II. 应用
复杂基因组或基因模板,低拷贝扩增模板,多重PCR等。
III. 产品构成
Cat. No. C-2821 (100μg,100μl), –20°C保存。
• 100 μl Taq Antibody (1 μg/μl) in storage buffer:50 mM KCl, 10 mM Tris-HCl (pH 7.0), 50% glycerol
• 1.0 ml Dilution buffer: 50 mM KCl, 10 mM Tris-HCl (pH 7.0)
Cat. No. C-2822 (1mg,1ml), –20°C保存。
• 1 ml Taq Antibody (1 μg/μl) in storage buffer:50 mM KCl, 10 mM Tris-HCl (pH 7.0), 50% glycerol
• 8.0 ml Dilution buffer: 50 mM KCl, 10 mM Tris-HCl (pH 7.0)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验monoclonal anti-HA 16B12 (MMS101R, BAbCo, used at 1:200 to 1:1000 dilution) mouse monoclonal anti-HA 12CA5 (12CA5, Boehringer, used at 1:200 dilution) rabbit polyclonal anti-HA (RS1010C, BAbCo, used at 1:200 dilution) Cy3-conjugated affinity
Anti-HA Immunocytology The multiple copies of the HA epitope present in the HAT tag can be detected by the mouse monoclonal antibodies 12CA5 (Boehringer) and 16B12 (MMS101R; BAbCO, Richmond, California) (see Table 1). On Western blots
The Application of Monoclonal Antibodies in the Treatment of Lymphoma
lymphoma treated with a chimeric anti-CD20 mAb, and Maloney and co-workers (2 ) recently reported a 50% response rate in relapsed, low-grade, NHL, with a 10---11 mo duration. Encouragingly, patients in these studies did not raise antibody responses
技术资料暂无技术资料 索取技术资料






